Notice of Correction for Reporting Progress and Requesting Support for the Development of Clinical Projects for RFA-AI-12-059 “Autoimmunity Centers of Excellence, Clinical Research Program (UM1)”


Notice Number: NOT-AI-13-041


Key Dates

Release Date:   April 22, 2013

Related Announcements

RFA-AI-12-059

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice (1) corrects a sentence, (2) provides guidance on reporting progress by current ACE grantees, and (3) provides guidance and instructions on requesting funds to support Clinical Project development.

Section IV. Application and Submission Information


Center Research Agenda (Program Overview)


Research Plan (Center Research Agenda)

The FOA states “Applicants should describe the central theme of the proposed Program and explain how the proposed Principal, Pilot, and Collaborative Projects fit under the overarching Program theme”.  This is incorrect; applications to this FOA cannot propose Principal or Pilot Projects. Therefore, the sentence is corrected to read “Applicants should describe the central theme of the proposed Program and explain how the proposed Primary and Alternate Clinical Projects and the Collaborative Project (if proposed) fit under the overarching Program theme”

The FOA states that a Progress Report is “[r]equired for renewal applications; not applicable for new applications”.  However, all UM1 applications will be new.  Therefore, applicants who are supported by the current ACE must include within the “Research Strategy” section of the Center Research Agenda a report on their progress during this period of support. This information is essential for a satisfactory review of the UM1 application.

Section II. Award Information


Award Budget

The FOA states that “this FOA will fund successful applicants up to $50,000 per year direct costs for planning further development of successful Clinical Trial Projects."  However, the FOA did not explain where this support could be requested or budgeted.  This notice amends the FOA (a) to explain that applicants may request support for Clinical Project development within the Administrative Core and (b) to increase the cap on Administrative Core budget to $100,000 direct costs (from the current $50,000 direct costs) to accommodate such requests.

Applicants requesting support for Clinical Project development should justify the costs based on their proposed Primary Clinical Project and explain how, once development of the Primary Clinical Project is complete, this support will be shifted to developing other Clinical Projects with the ACE.

Inquiries

Please direct all inquiries to:

David Johnson, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-496-7104
Email: David.Johnson@NIH.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.